Envoy Medical, Inc. (COCH)

Envoy Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-21.79	-20.8	-29.92	-15.92	-0.25
Depreciation & Amortization	0.27	0.17	0.13	0.08	-
Stock-Based Compensation	0.63	0.56	1.58	-	-
Other Adjustments	1.33	2.75	12.11	7.2	-4.45
Change in Receivables	0.18	-0.57	-0.21	0.05	-
Changes in Inventories	-0.14	-0.38	-0.01	-0.19	-
Changes in Accounts Payable	0.75	-0.02	0.55	0.34	0.62
Changes in Accrued Expenses	-0.22	-0.42	-0.34	-0.39	2.06
Changes in Other Operating Activities	-0.73	0.76	-0.98	0.03	-1.21
Operating Cash Flow	-16.9	-17.95	-17.09	-8.81	-3.24
Capital Expenditures	0.53	-0.98	-0.15	-0.22	-
Other Investing Activities	-	-	-	-	-425
Investing Cash Flow	0.53	-0.98	-0.15	-0.22	-425
Long-Term Debt Issued	20	20	10	8	-
Long-Term Debt Repaid	-0.85	-0.92	-0.56	-	-
Net Long-Term Debt Issued (Repaid)	14.15	19.08	9.44	8	-
Issuance of Common Stock	0.45	1.75	11.85	-	425
Net Common Stock Issued (Repurchased)	0.45	1.75	11.85	-	425
Preferred Share Dividends Paid	-2.43	-2.45	-	-	-
Other Financing Activities	1.54	1.82	-	0.09	3.37
Financing Cash Flow	15.51	20.2	21.28	8.09	428.37
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0	-0.01	-0	-0.01	-
Net Cash Flow	-0.94	1.27	4.04	-0.94	0.12
Free Cash Flow	-16.38	-18.93	-17.24	-9.02	-3.24
FCF Margin	-7873.56%	-8412.89%	-5456.96%	-3807.17%	-
Free Cash Flow Per Share	-0.78	-1.01	-1.40	-0.89	-0.32
Levered Free Cash Flow	-9	-9.76	-22.63	-8.27	1.21
Unlevered Free Cash Flow	-19.97	-20.13	-19.16	-9.06	1.46

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q